RXO (NYSE: RXO) reported Q2 EPS of ($0.06), $0.17 worse than the analyst estimate of $0.11. Revenue for the quarter came in at $930 billion versus the consensus estimate of $1 billion.

Third-Quarter Outlook

RXO expects third-quarter 2024 companywide adjusted EBITDA to be between $28 million and $34 million. The company expects third-quarter 2024 Brokerage gross margin to be between 13% and 15%.

For earnings history and earnings-related data on RXO (RXO) click here.